Risk Factors for Recurrent L4-5 Disc Herniation After Percutaneous Endoscopic Transforaminal Discectomy: A Retrospective Analysis of 654 Cases
Overview
Affiliations
Background: Percutaneous endoscopic lumbar discectomy (PELD) is an increasingly applied minimally invasive procedure that has several advantages in the treatment of lumbar disc herniation (LDH). However, recurrent LDH (rLDH) has become a concerning postoperative complication. It remains difficult to establish a consensus and draw reliable conclusions regarding the risk factors for rLDH.
Purpose: This retrospective study aimed to investigate the risk factors associated with rLDH at the L4-5 level after percutaneous endoscopic transforaminal discectomy (PETD).
Methods: A total of 654 patients who underwent the PETD procedure at the L4-5 level from October 2013 to January 2020 were divided into a recurrence (R) group (n=46) and a nonrecurrence (N) group (n=608). Demographic and clinical data and imaging parameters were collected and analyzed using univariate and multiple regression analyses.
Results: The current study found a 7% rate of rLDH at the L4/5 level after successful PETD. Univariate analysis showed that older age, high BMI, diabetes mellitus history, smoking, large physical load intensity, moderate disc degeneration, small muscle-disc ratio (M/D), more fat infiltration, large sagittal range of motion (sROM), scoliosis, small disc height index (DHI), small intervertebral space angle (ISA), and small lumbar lordosis (LL) were potential risk factors (P < 0.10) for LDH recurrence after PETD at the L4-5 level. Multivariate analysis suggested that high BMI, large physical load intensity, moderate disc degeneration, small M/D, more fat infiltration, large sROM, small ISA, and small LL were independent significant risk factors for recurrence of LDH after PETD.
Conclusion: Consideration of disc degeneration, M/D, fat infiltration of the paravertebral muscles, sROM, ISA, LL, BMI, and physical load intensity prior to surgical intervention may contribute to the prevention of rLDH following PETD and lead to a more satisfactory operative outcome and the development of a reasonable rehabilitation program after discharge.
Zhou Y, Huang R, Liu Y, Feng C Medicine (Baltimore). 2024; 103(49):e40828.
PMID: 39654179 PMC: 11631013. DOI: 10.1097/MD.0000000000040828.
Lin A, Zhang H, Wang Y, Cui Q, Zhu K, Zhou D BMC Med Imaging. 2024; 24(1):273.
PMID: 39390384 PMC: 11468133. DOI: 10.1186/s12880-024-01450-x.
Zhang S, Tong M, Li S, Zhang B, Zhang W, Wang R Orthop Surg. 2024; 16(11):2587-2597.
PMID: 39205477 PMC: 11541140. DOI: 10.1111/os.14209.
Tang M, Wang S, Wang Y, Zeng F, Chen M, Chang X J Pain Res. 2024; 17:2121-2131.
PMID: 38894861 PMC: 11185253. DOI: 10.2147/JPR.S459846.
Shen Z, Wang W, Ni L, Zhao H, Yang L, Yang H BMC Musculoskelet Disord. 2024; 25(1):267.
PMID: 38582848 PMC: 10998392. DOI: 10.1186/s12891-024-07376-3.